Scarica l'app Stockscreener
1.68
3.70%
0.06
Chemomab Therapeutics Ltd Adr Azioni (CMMB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Operating Expenses
|
4.71%
9.049
|
8.642 | 8.317 | 6.254 | 5.32 |
| Income/Loss From Continuing Operations Before Tax |
5.69%
-8.732
|
-8.262 | -8.08 | -6.734 | -5.104 |
| Income Tax Expense/Benefit |
110.00%
0.021
|
0.01 | - | -0.544 | - |
| Income/Loss From Continuing Operations After Tax |
5.81%
-8.753
|
-8.272 | -8.08 | -6.19 | -5.104 |
|
Net Income/Loss
|
5.81%
-8.753
|
-8.272 | -8.08 | -6.19 | -5.104 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
29,185%
221.00
|
-0.7598 | 228.77 | 228.17 | -0.041 |
| Diluted Average Shares |
29,185%
221.00
|
-0.7598 | 228.77 | 228.17 | -0.041 |
| Basic Earnings Per Share |
11.11%
0.04
|
0.036 | 0.035 | 0.027 | 0.023 |
| Diluted Earnings Per Share |
11.11%
0.04
|
0.036 | 0.035 | 0.027 | 0.023 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):